SIMILAR PATTERNS OF AMINO ACIDS FOR 4KUK_A_RBFA201_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1as4 | ANTICHYMOTRYPSIN (Homo sapiens) |
PF00079(Serpin) | 5 | ASN A 104ASN B 381ASN A 30LEU A 55ILE A 188 | None | 1.49A | 4kukA-1as4A:undetectable | 4kukA-1as4A:17.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ji6 | PESTICIDIAL CRYSTALPROTEIN CRY3BB (Bacillusthuringiensis) |
PF00555(Endotoxin_M)PF03944(Endotoxin_C)PF03945(Endotoxin_N) | 5 | VAL A 264GLN A 485LEU A 312ILE A 491GLN A 316 | None | 1.48A | 4kukA-1ji6A:undetectable | 4kukA-1ji6A:12.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1jn1 | 2C-METHYL-D-ERYTHRITOL2,4-CYCLODIPHOSPHATESYNTHASE (Haemophilusinfluenzae) |
PF02542(YgbB) | 5 | VAL A 95CYH A 123GLN A 122LEU A 78ILE A 49 | None | 1.37A | 4kukA-1jn1A:undetectable | 4kukA-1jn1A:25.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 5 | ASN A 965CYH A 966ASN A1008ILE A 982GLN A1029 | FMN A1033 (-3.2A)FMN A1033 (-1.8A)FMN A1033 (-4.1A)FMN A1033 (-4.3A)FMN A1033 (-4.2A) | 1.26A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 9 | VAL A 932ASN A 941ASN A 965CYH A 966ARG A 967GLN A 970ASN A 998ASN A1008GLN A1029 | NoneFMN A1033 ( 4.4A)FMN A1033 (-3.2A)FMN A1033 (-1.8A)FMN A1033 (-3.6A)FMN A1033 (-3.1A)FMN A1033 (-3.2A)FMN A1033 (-4.1A)FMN A1033 (-4.2A) | 0.57A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jnu | PHY3 PROTEIN (Adiantumcapillus-veneris) |
PF13426(PAS_9) | 5 | VAL A 932ASN A 941ASN A 965CYH A 966ASN A 998 | NoneFMN A1033 ( 4.4A)FMN A1033 (-3.2A)FMN A1033 (-1.8A)FMN A1033 (-3.2A) | 1.33A | 4kukA-1jnuA:19.4 | 4kukA-1jnuA:34.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n9l | PUTATIVE BLUE LIGHTRECEPTOR (Chlamydomonasreinhardtii) |
PF13426(PAS_9) | 5 | CYH A 57ASN A 99LEU A 101ILE A 73GLN A 120 | FMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-4.1A)FMN A 500 ( 4.2A)FMN A 500 (-3.7A) | 1.44A | 4kukA-1n9lA:18.9 | 4kukA-1n9lA:36.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n9l | PUTATIVE BLUE LIGHTRECEPTOR (Chlamydomonasreinhardtii) |
PF13426(PAS_9) | 9 | VAL A 23ASN A 56CYH A 57ARG A 58GLN A 61ASN A 89ASN A 99LEU A 101GLN A 120 | NoneFMN A 500 (-2.9A)FMN A 500 (-3.4A)FMN A 500 (-4.0A)FMN A 500 (-3.3A)FMN A 500 (-3.0A)FMN A 500 (-3.9A)FMN A 500 (-4.1A)FMN A 500 (-3.7A) | 0.38A | 4kukA-1n9lA:18.9 | 4kukA-1n9lA:36.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nlr | ENDO-1,4-BETA-GLUCANASE (Streptomyceslividans) |
PF01670(Glyco_hydro_12) | 5 | SER A 102ASN A 100GLN A 30ASN A 21GLN A 20 | MHO A 122 ( 4.1A)MHO A 122 ( 4.7A)NoneNoneNone | 1.31A | 4kukA-1nlrA:undetectable | 4kukA-1nlrA:19.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vko | INOSITOL-3-PHOSPHATESYNTHASE (Caenorhabditiselegans) |
PF01658(Inos-1-P_synth)PF07994(NAD_binding_5) | 5 | SER A 364ASN A 238ASN A 351LEU A 352ILE A 392 | NoneNAD A 601 (-3.5A)NoneNoneNone | 1.47A | 4kukA-1vkoA:undetectable | 4kukA-1vkoA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xv9 | ORPHAN NUCLEARRECEPTOR NR1I3 (Homo sapiens) |
PF00104(Hormone_recep) | 5 | VAL B 172CYH B 202ASN B 165LEU B 343ILE B 346 | None | 1.46A | 4kukA-1xv9B:undetectable | 4kukA-1xv9B:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2btw | ALR0975 PROTEIN (Nostoc sp. PCC7120) |
PF05023(Phytochelatin) | 5 | VAL A 139SER A 238ASN A 165ASN A 159GLN A 155 | None | 1.46A | 4kukA-2btwA:undetectable | 4kukA-2btwA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ek8 | AMINOPEPTIDASE (Aneurinibacillussp. AM-1) |
PF02225(PA)PF04389(Peptidase_M28) | 5 | SER A 243ASN A 239LEU A 360ILE A 362GLN A 299 | None | 1.39A | 4kukA-2ek8A:undetectable | 4kukA-2ek8A:15.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i0z | NAD(FAD)-UTILIZINGDEHYDROGENASES (Bacillus cereus) |
PF03486(HI0933_like) | 5 | VAL A 112ASN A 50CYH A 49LEU A 405ILE A 83 | None CL A 424 (-4.8A)NoneNoneNone | 1.43A | 4kukA-2i0zA:undetectable | 4kukA-2i0zA:15.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | VAL A 28ASN A 37ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 900 ( 4.9A)FMN A 900 (-3.9A)FMN A 900 (-4.3A)FMN A 900 ( 4.1A)FMN A 900 (-4.2A) | 0.77A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | VAL A 28ASN A 61CYH A 62ASN A 104LEU A 106ILE A 108 | NoneFMN A 900 (-2.0A)FMN A 900 (-3.3A)FMN A 900 (-3.9A)FMN A 900 (-4.3A)FMN A 900 ( 4.1A) | 1.27A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 9 | VAL A 28ASN A 61CYH A 62GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 900 (-2.0A)FMN A 900 (-3.3A)FMN A 900 (-2.6A)FMN A 900 (-2.9A)FMN A 900 (-3.9A)FMN A 900 (-4.3A)FMN A 900 ( 4.1A)FMN A 900 (-4.2A) | 0.85A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mwg | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF01740(STAS)PF13426(PAS_9) | 6 | VAL A 28CYH A 62ARG A 63ASN A 94ASN A 104GLN A 123 | NoneFMN A 900 (-3.3A)FMN A 900 (-4.9A)FMN A 900 (-2.9A)FMN A 900 (-3.9A)FMN A 900 (-4.2A) | 1.18A | 4kukA-2mwgA:14.8 | 4kukA-2mwgA:22.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2paa | PHOSPHOGLYCERATEKINASE, TESTISSPECIFIC (Mus musculus) |
PF00162(PGK) | 5 | VAL A 58SER A 114CYH A 107GLN A 105LEU A 95 | None | 1.25A | 4kukA-2paaA:undetectable | 4kukA-2paaA:15.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pr5 | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF13426(PAS_9) | 11 | VAL A 28ASN A 37ASN A 61CYH A 62ARG A 63GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-3.5A)FMN A 500 (-3.8A)FMN A 500 (-3.1A)FMN A 500 (-3.1A)FMN A 500 (-3.7A)FMN A 500 (-4.1A)FMN A 500 (-4.2A)FMN A 500 (-3.9A) | 0.38A | 4kukA-2pr5A:17.1 | 4kukA-2pr5A:33.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pr5 | BLUE-LIGHTPHOTORECEPTOR (Bacillussubtilis) |
PF13426(PAS_9) | 5 | VAL A 28ASN A 61LEU A 106ILE A 108GLN A 123 | NoneFMN A 500 (-3.2A)FMN A 500 (-4.1A)FMN A 500 (-4.2A)FMN A 500 (-3.9A) | 1.17A | 4kukA-2pr5A:17.1 | 4kukA-2pr5A:33.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 5 | ASN A 449CYH A 450ASN A 492ILE A 466GLN A 513 | FMN A1725 (-3.0A)FMN A1725 (-3.4A)FMN A1725 (-3.8A)FMN A1725 (-4.2A)FMN A1725 (-3.8A) | 1.47A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 8 | VAL A 416ASN A 425ASN A 449ARG A 451GLN A 454ASN A 482ASN A 492GLN A 513 | NoneFMN A1725 (-3.8A)FMN A1725 (-3.0A)FMN A1725 (-3.8A)FMN A1725 (-3.1A)FMN A1725 (-3.0A)FMN A1725 (-3.8A)FMN A1725 (-3.8A) | 0.43A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 7 | VAL A 416ASN A 449CYH A 450ARG A 451GLN A 454ASN A 492GLN A 513 | NoneFMN A1725 (-3.0A)FMN A1725 (-3.4A)FMN A1725 (-3.8A)FMN A1725 (-3.1A)FMN A1725 (-3.8A)FMN A1725 (-3.8A) | 0.83A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wkp | NPH1-1, RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 5 | VAL A 416ASN A 449CYH A 450ARG A 451LEU A 496 | NoneFMN A1725 (-3.0A)FMN A1725 (-3.4A)FMN A1725 (-3.8A)FMN A1725 (-4.8A) | 1.16A | 4kukA-2wkpA:18.0 | 4kukA-2wkpA:22.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | SER A 202ASN A 233ARG A 235GLN A 238ASN A 266ASN A 276LEU A 278ILE A 280 | FMN A 500 (-3.6A)FMN A 500 (-3.0A)FMN A 500 (-3.9A)FMN A 500 (-3.0A)FMN A 500 (-3.0A)FMN A 500 (-3.6A)FMN A 500 (-4.3A)FMN A 500 ( 4.6A) | 0.69A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 10 | VAL A 200ASN A 233CYH A 234ARG A 235GLN A 238ASN A 266ASN A 276LEU A 278ILE A 280GLN A 297 | NoneFMN A 500 (-3.0A)FMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-3.0A)FMN A 500 (-3.0A)FMN A 500 (-3.6A)FMN A 500 (-4.3A)FMN A 500 ( 4.6A)FMN A 500 (-3.6A) | 0.52A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6c | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 5 | VAL A 200ASN A 233LEU A 278ILE A 280GLN A 297 | NoneFMN A 500 (-3.0A)FMN A 500 (-4.3A)FMN A 500 ( 4.6A)FMN A 500 (-3.6A) | 1.26A | 4kukA-2z6cA:16.6 | 4kukA-2z6cA:38.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6d | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | SER A 138ASN A 169ARG A 171GLN A 174ASN A 202ASN A 212LEU A 214GLN A 233 | FMN A 500 (-3.6A)FMN A 500 (-3.0A)FMN A 500 (-3.7A)FMN A 500 (-3.0A)FMN A 500 (-3.1A)FMN A 500 (-3.7A)FMN A 500 (-4.3A)FMN A 500 (-3.8A) | 0.67A | 4kukA-2z6dA:19.0 | 4kukA-2z6dA:36.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2z6d | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 9 | VAL A 136ASN A 169CYH A 170ARG A 171GLN A 174ASN A 202ASN A 212LEU A 214GLN A 233 | NoneFMN A 500 (-3.0A)FMN A 500 (-3.5A)FMN A 500 (-3.7A)FMN A 500 (-3.0A)FMN A 500 (-3.1A)FMN A 500 (-3.7A)FMN A 500 (-4.3A)FMN A 500 (-3.8A) | 0.28A | 4kukA-2z6dA:19.0 | 4kukA-2z6dA:36.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zle | PROTEASE DO (Escherichiacoli) |
PF00595(PDZ)PF13365(Trypsin_2) | 5 | VAL A 145ASN A 152ASN A 180LEU A 169ILE A 177 | None | 1.47A | 4kukA-2zleA:undetectable | 4kukA-2zleA:16.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zyl | POSSIBLEOXIDOREDUCTASE (Mycobacteriumtuberculosis) |
PF00355(Rieske) | 5 | ASN A 257GLN A 204ASN A 195LEU A 329ILE A 173 | None | 1.27A | 4kukA-2zylA:undetectable | 4kukA-2zylA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ayt | PUTATIVEUNCHARACTERIZEDPROTEIN TTHB071 (Thermusthermophilus) |
PF01261(AP_endonuc_2) | 5 | VAL A 168SER A 170ASN A 137ASN A 189LEU A 206 | None | 1.10A | 4kukA-3aytA:undetectable | 4kukA-3aytA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ezo | MALONYL COA-ACYLCARRIER PROTEINTRANSACYLASE (Burkholderiapseudomallei) |
PF00698(Acyl_transf_1) | 5 | ARG A 112ASN A 54LEU A 53ILE A 45GLN A 12 | None | 1.41A | 4kukA-3ezoA:undetectable | 4kukA-3ezoA:17.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gm8 | GLYCOSIDE HYDROLASEFAMILY 2, CANDIDATEBETA-GLYCOSIDASE (Bacteroidesvulgatus) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N)PF16355(DUF4982) | 5 | SER A 713ASN A 714GLN A 788LEU A 755ILE A 812 | None | 1.28A | 4kukA-3gm8A:undetectable | 4kukA-3gm8A:11.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3htk | E3 SUMO-PROTEINLIGASE MMS21 (Saccharomycescerevisiae) |
PF11789(zf-Nse) | 5 | VAL C 236SER C 197ASN C 201GLN C 165ASN C 140 | None | 1.36A | 4kukA-3htkC:undetectable | 4kukA-3htkC:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3oja | ANOPHELESPLASMODIUM-RESPONSIVE LEUCINE-RICHREPEAT PROTEIN 1 (Anophelesgambiae) |
PF13855(LRR_8) | 5 | ARG B 354ASN B 348ASN B 329LEU B 310ILE B 289 | None | 1.48A | 4kukA-3ojaB:undetectable | 4kukA-3ojaB:15.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 5 | ASN A 74CYH A 75ASN A 117ILE A 91GLN A 138 | FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-4.1A)FMN A 500 (-3.9A)FMN A 500 (-3.9A) | 1.12A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 9 | VAL A 41SER A 43ASN A 50ASN A 74CYH A 75ARG A 76ASN A 107ASN A 117GLN A 138 | NoneFMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-3.8A)FMN A 500 (-3.1A)FMN A 500 (-4.1A)FMN A 500 (-3.9A) | 0.46A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 6 | VAL A 41SER A 43ASN A 50ASN A 74CYH A 75ASN A 107 | NoneFMN A 500 (-3.4A)FMN A 500 (-3.9A)FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-3.1A) | 1.21A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p7n | SENSOR HISTIDINEKINASE (Erythrobacterlitoralis) |
PF00196(GerE)PF13426(PAS_9) | 5 | VAL A 121ASN A 117ASN A 107ASN A 74LEU A 52 | FMN A 500 (-4.5A)FMN A 500 (-4.1A)FMN A 500 (-3.1A)FMN A 500 (-3.1A)None | 1.49A | 4kukA-3p7nA:19.3 | 4kukA-3p7nA:29.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qp8 | CVIR TRANSCRIPTIONALREGULATOR (Chromobacteriumviolaceum) |
PF03472(Autoind_bind) | 5 | VAL A 109ARG A 101GLN A 68LEU A 104ILE A 153 | None | 1.18A | 4kukA-3qp8A:2.5 | 4kukA-3qp8A:24.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 5 | ARG B 109GLN B 112ASN B 151ASN B 161ILE B 74 | FAD B5201 (-4.3A)FAD B5201 (-3.1A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-4.9A) | 1.37A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 6 | ARG B 124ASN B 151ASN B 161LEU B 163ILE B 165GLN B 182 | FAD B5201 (-3.4A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-3.8A)FAD B5201 ( 4.1A)FAD B5201 (-4.1A) | 1.37A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 9 | ASN B 107CYH B 108ARG B 109GLN B 112ASN B 151ASN B 161LEU B 163ILE B 165GLN B 182 | FAD B5201 (-3.2A)FAD B5201 (-1.8A)FAD B5201 (-4.3A)FAD B5201 (-3.1A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-3.8A)FAD B5201 ( 4.1A)FAD B5201 (-4.1A) | 0.57A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3rh8 | VIVID PAS PROTEINVVD (Neurosporacrassa) |
PF13426(PAS_9) | 6 | SER B 178GLN B 112ASN B 151ASN B 161LEU B 163GLN B 182 | FAD B5201 (-3.3A)FAD B5201 (-3.1A)FAD B5201 (-3.0A)FAD B5201 (-3.7A)FAD B5201 (-3.8A)FAD B5201 (-4.1A) | 0.93A | 4kukA-3rh8B:17.5 | 4kukA-3rh8B:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 9 | ASN A 44ASN A 68ARG A 70GLN A 73ASN A 101ASN A 111LEU A 113ILE A 115GLN A 132 | FMN A 200 (-4.0A)FMN A 200 (-3.1A)FMN A 200 (-3.9A)FMN A 200 (-3.1A)FMN A 200 (-3.1A)FMN A 200 (-3.8A)FMN A 200 (-4.3A)FMN A 200 (-4.3A)FMN A 200 (-3.9A) | 0.53A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 8 | ASN A 68CYH A 69ARG A 70GLN A 73ASN A 111LEU A 113ILE A 115GLN A 132 | FMN A 200 (-3.1A)FMN A 200 (-3.4A)FMN A 200 (-3.9A)FMN A 200 (-3.1A)FMN A 200 (-3.8A)FMN A 200 (-4.3A)FMN A 200 (-4.3A)FMN A 200 (-3.9A) | 0.81A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t50 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE (Brucellamelitensis) |
PF13426(PAS_9) | 5 | GLN A 73ASN A 101ASN A 111LEU A 113ILE A 95 | FMN A 200 (-3.1A)FMN A 200 (-3.1A)FMN A 200 (-3.8A)FMN A 200 (-4.3A)None | 1.12A | 4kukA-3t50A:19.5 | 4kukA-3t50A:39.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ue6 | AUREOCHROME1 (Vaucheriafrigida) |
PF13426(PAS_9) | 8 | VAL A 220ASN A 229ASN A 253ARG A 255GLN A 258ASN A 286ASN A 296GLN A 317 | NoneFMN A 500 (-3.9A)FMN A 500 (-3.1A)FMN A 500 (-3.6A)FMN A 500 (-3.1A)FMN A 500 (-3.3A)FMN A 500 (-4.3A)FMN A 500 (-4.1A) | 0.43A | 4kukA-3ue6A:19.3 | 4kukA-3ue6A:35.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ue6 | AUREOCHROME1 (Vaucheriafrigida) |
PF13426(PAS_9) | 7 | VAL A 220ASN A 253CYH A 254ARG A 255GLN A 258ASN A 296GLN A 317 | NoneFMN A 500 (-3.1A)FMN A 500 (-3.5A)FMN A 500 (-3.6A)FMN A 500 (-3.1A)FMN A 500 (-4.3A)FMN A 500 (-4.1A) | 0.72A | 4kukA-3ue6A:19.3 | 4kukA-3ue6A:35.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zmr | CELLULASE (GLYCOSYLHYDROLASE FAMILY 5) (Bacteroidesovatus) |
PF00150(Cellulase)PF13004(BACON) | 5 | VAL A 110SER A 82CYH A 80LEU A 52ILE A 63 | None | 1.45A | 4kukA-3zmrA:undetectable | 4kukA-3zmrA:15.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4ees | PHOTOTROPIN-2 (Arabidopsisthaliana) |
PF13426(PAS_9) | 9 | VAL A 392ASN A 401ASN A 425ARG A 427GLN A 430ASN A 458ASN A 468LEU A 470GLN A 489 | NoneFMN A1001 (-3.8A)FMN A1001 (-3.0A)FMN A1001 (-3.8A)FMN A1001 (-3.2A)FMN A1001 (-3.0A)FMN A1001 (-3.9A)FMN A1001 (-4.2A)FMN A1001 (-3.9A) | 0.32A | 4kukA-4eesA:20.2 | 4kukA-4eesA:34.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 5 | ASN A 61CYH A 62ASN A 104LEU A 106ILE A 78 | FMN A 401 (-3.1A)FMN A 401 (-3.3A)FMN A 401 (-3.7A)FMN A 401 (-4.3A)FMN A 401 (-4.1A) | 1.44A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 10 | VAL A 28ASN A 37ASN A 61ARG A 63GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 401 (-4.1A)FMN A 401 (-3.1A)FMN A 401 (-3.9A)FMN A 401 (-3.2A)FMN A 401 (-3.1A)FMN A 401 (-3.7A)FMN A 401 (-4.3A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 0.33A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 10 | VAL A 28ASN A 61CYH A 62ARG A 63GLN A 66ASN A 94ASN A 104LEU A 106ILE A 108GLN A 123 | NoneFMN A 401 (-3.1A)FMN A 401 (-3.3A)FMN A 401 (-3.9A)FMN A 401 (-3.2A)FMN A 401 (-3.1A)FMN A 401 (-3.7A)FMN A 401 (-4.3A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 0.62A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gcz | BLUE-LIGHTPHOTORECEPTOR,SENSOR PROTEIN FIXL (Bacillussubtilis;Bradyrhizobiumdiazoefficiens) |
PF00512(HisKA)PF02518(HATPase_c)PF13426(PAS_9) | 5 | VAL A 28ASN A 61LEU A 106ILE A 108GLN A 123 | NoneFMN A 401 (-3.1A)FMN A 401 (-4.3A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 1.22A | 4kukA-4gczA:17.7 | 4kukA-4gczA:17.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hhd | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | VAL A 478ASN A 487ASN A 511ARG A 513GLN A 516ASN A 544ASN A 554GLN A 575 | NoneFMN A 701 (-3.7A)FMN A 701 (-2.9A)FMN A 701 (-2.6A)FMN A 701 (-3.3A)FMN A 701 (-2.8A)FMN A 701 (-3.8A)FMN A 701 (-3.6A) | 0.57A | 4kukA-4hhdA:19.2 | 4kukA-4hhdA:32.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hhd | PHOTOTROPIN-1 (Arabidopsisthaliana) |
PF13426(PAS_9) | 8 | VAL A 478ASN A 487ASN A 511CYH A 512ARG A 513GLN A 516ASN A 554GLN A 575 | NoneFMN A 701 (-3.7A)FMN A 701 (-2.9A)FMN A 701 (-3.7A)FMN A 701 (-2.6A)FMN A 701 (-3.3A)FMN A 701 (-3.8A)FMN A 701 (-3.6A) | 0.81A | 4kukA-4hhdA:19.2 | 4kukA-4hhdA:32.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hj3 | LOV PROTEIN (Rhodobactersphaeroides) |
PF13426(PAS_9) | 8 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | FMN A 201 (-3.1A)FMN A 201 (-3.7A)FMN A 201 (-3.4A)FMN A 201 (-3.6A)FMN A 201 (-2.9A)FMN A 201 (-3.8A)FMN A 201 (-4.4A)FMN A 201 (-3.8A) | 0.73A | 4kukA-4hj3A:15.0 | 4kukA-4hj3A:29.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hwt | THREONINE--TRNALIGASE, CYTOPLASMIC (Homo sapiens) |
PF00587(tRNA-synt_2b)PF03129(HGTP_anticodon) | 5 | ASN A 704ARG A 724GLN A 702LEU A 365ILE A 385 | None | 1.11A | 4kukA-4hwtA:undetectable | 4kukA-4hwtA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o5j | UNCHARACTERIZEDPROTEIN (Helicobacterpylori) |
no annotation | 5 | SER A 190ASN A 194LEU A 94ILE A 90GLN A 159 | NoneNoneNoneNoneGOL A 503 (-4.1A) | 1.27A | 4kukA-4o5jA:undetectable | 4kukA-4o5jA:13.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qdf | 3-KETOSTEROID9ALPHA-HYDROXYLASEOXYGENASE (Rhodococcusrhodochrous) |
PF00355(Rieske) | 5 | ASN B 258GLN B 204ASN B 195LEU B 330ILE B 173 | 30Q B 403 ( 4.7A)30Q B 403 (-4.0A)NoneNoneNone | 1.24A | 4kukA-4qdfB:undetectable | 4kukA-4qdfB:15.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r38 | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF13426(PAS_9) | 8 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 201 (-2.6A)RBF A 201 (-3.3A)RBF A 201 (-3.7A)RBF A 201 (-3.0A)RBF A 201 (-2.4A)RBF A 201 (-3.7A)RBF A 201 (-4.2A)RBF A 201 (-4.0A) | 0.39A | 4kukA-4r38A:18.4 | 4kukA-4r38A:36.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r3a | BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2 (Erythrobacterlitoralis) |
PF07568(HisKA_2)PF13426(PAS_9)PF13581(HATPase_c_2) | 8 | ASN A 54CYH A 55ARG A 56GLN A 59ASN A 87ASN A 97LEU A 99GLN A 118 | RBF A 402 (-2.9A)RBF A 402 (-3.4A)RBF A 402 (-3.6A)RBF A 402 (-3.3A)RBF A 402 (-2.3A)RBF A 402 (-4.0A)RBF A 402 (-4.3A)RBF A 402 (-4.3A) | 0.34A | 4kukA-4r3aA:14.6 | 4kukA-4r3aA:16.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4wuj | GLYCOSIDE HYDROLASEFAMILY 15, CELLULOSESIGNALING ASSOCIATEDPROTEIN ENVOY (Trichodermareesei) |
PF13426(PAS_9) | 8 | ASN A 134CYH A 135ARG A 136GLN A 139ASN A 173ASN A 183ILE A 187GLN A 204 | FMN A5201 (-2.5A)FMN A5201 (-3.5A)FMN A5201 (-3.7A)FMN A5201 (-3.1A)FMN A5201 (-2.4A)FMN A5201 (-4.1A)FMN A5201 (-4.0A)FMN A5201 (-3.7A) | 0.65A | 4kukA-4wujA:16.5 | 4kukA-4wujA:35.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xmm | NUCLEOPORIN NUP120 (Saccharomycescerevisiae) |
no annotation | 5 | ASN E 94GLN E 477ASN E 480ASN E 10LEU E 12 | None | 1.38A | 4kukA-4xmmE:undetectable | 4kukA-4xmmE:8.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y9l | PROTEIN ACDH-11,ISOFORM B (Caenorhabditiselegans) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M) | 5 | VAL A 575SER A 571ASN A 569LEU A 388ILE A 51 | None | 1.09A | 4kukA-4y9lA:undetectable | 4kukA-4y9lA:11.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 9 | VAL A 253ASN A 262ASN A 286ARG A 288GLN A 291ASN A 319ASN A 329ILE A 333GLN A 350 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-4.1A)FMN A 500 (-3.0A)FMN A 500 (-3.0A)FMN A 500 (-4.2A)NoneFMN A 500 (-3.9A) | 0.48A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 8 | VAL A 253ASN A 262ASN A 286CYH A 287ARG A 288GLN A 291ILE A 333GLN A 350 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-3.6A)FMN A 500 (-4.1A)FMN A 500 (-3.0A)NoneFMN A 500 (-3.9A) | 0.75A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5a8b | PTAUREO1A LOV2DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 6 | VAL A 253ASN A 262ASN A 286CYH A 287ASN A 319ILE A 333 | NoneFMN A 500 (-3.8A)FMN A 500 (-3.2A)FMN A 500 (-3.6A)FMN A 500 (-3.0A)None | 1.33A | 4kukA-5a8bA:19.3 | 4kukA-5a8bA:36.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dju | NPH1-2 (Avena sativa) |
PF13426(PAS_9) | 8 | VAL A 416ASN A 425ASN A 449ARG A 451GLN A 454ASN A 482ASN A 492GLN A 513 | NoneFMN A 601 ( 3.9A)FMN A 601 ( 3.1A)FMN A 601 ( 3.8A)FMN A 601 (-3.1A)FMN A 601 (-3.1A)FMN A 601 (-3.9A)FMN A 601 (-3.8A) | 0.47A | 4kukA-5djuA:17.3 | 4kukA-5djuA:30.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 5 | ASN A 286CYH A 287ASN A 329ILE A 303GLN A 350 | FMN A 401 (-3.0A)FMN A 401 (-3.4A)FMN A 401 (-4.1A)FMN A 401 (-4.2A)FMN A 401 (-3.8A) | 1.44A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 9 | VAL A 253ASN A 262ASN A 286ARG A 288GLN A 291ASN A 319ASN A 329ILE A 333GLN A 350 | NoneFMN A 401 (-3.7A)FMN A 401 (-3.0A)FMN A 401 (-4.1A)FMN A 401 (-2.8A)FMN A 401 (-3.0A)FMN A 401 (-4.1A)NoneFMN A 401 (-3.8A) | 0.55A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 9 | VAL A 253ASN A 262ASN A 286CYH A 287ARG A 288GLN A 291ASN A 329ILE A 333GLN A 350 | NoneFMN A 401 (-3.7A)FMN A 401 (-3.0A)FMN A 401 (-3.4A)FMN A 401 (-4.1A)FMN A 401 (-2.8A)FMN A 401 (-4.1A)NoneFMN A 401 (-3.8A) | 0.75A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5dkk | LOV DOMAIN (Phaeodactylumtricornutum) |
PF13426(PAS_9) | 6 | VAL A 253ASN A 262ASN A 286CYH A 287ASN A 319ILE A 333 | NoneFMN A 401 (-3.7A)FMN A 401 (-3.0A)FMN A 401 (-3.4A)FMN A 401 (-3.0A)None | 1.27A | 4kukA-5dkkA:19.4 | 4kukA-5dkkA:36.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzh | RAS-RELATED C3BOTULINUM TOXINSUBSTRATE1,NPH1-1,RAS-RELATEDC3 BOTULINUM TOXINSUBSTRATE 1 (Avena sativa;Homo sapiens) |
PF00071(Ras)PF13426(PAS_9) | 8 | VAL A 63ASN A 72ASN A 96ARG A 98GLN A 101ASN A 129ASN A 139GLN A 160 | NoneFMN A 402 (-3.8A)FMN A 402 (-3.2A)FMN A 402 (-3.3A)FMN A 402 (-2.9A)FMN A 402 (-2.9A)FMN A 402 (-4.2A)FMN A 402 (-3.6A) | 0.37A | 4kukA-5hzhA:17.7 | 4kukA-5hzhA:25.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzk | INTERSECTIN-1,NPH1-1,INTERSECTIN-1 (Avena sativa;Homo sapiens) |
PF00621(RhoGEF)PF13426(PAS_9)PF16652(PH_13) | 8 | VAL B1321ASN B1330ASN B1354ARG B1356GLN B1359ASN B1387ASN B1397GLN B1418 | NoneFMN B1801 (-4.1A)FMN B1801 (-3.0A)FMN B1801 (-3.9A)FMN B1801 (-3.0A)FMN B1801 (-3.0A)FMN B1801 (-4.2A)FMN B1801 (-3.7A) | 0.46A | 4kukA-5hzkB:17.9 | 4kukA-5hzkB:16.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hzk | INTERSECTIN-1,NPH1-1,INTERSECTIN-1 (Avena sativa;Homo sapiens) |
PF00621(RhoGEF)PF13426(PAS_9)PF16652(PH_13) | 6 | VAL B1321ASN B1354CYH B1355ARG B1356GLN B1359GLN B1418 | NoneFMN B1801 (-3.0A)FMN B1801 (-3.5A)FMN B1801 (-3.9A)FMN B1801 (-3.0A)FMN B1801 (-3.7A) | 0.94A | 4kukA-5hzkB:17.9 | 4kukA-5hzkB:16.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j3w | SENSORY BOX PROTEIN (Pseudomonasputida) |
PF13426(PAS_9) | 9 | VAL A 19CYH A 53ARG A 54GLN A 57ASN A 85ASN A 95LEU A 97ILE A 99GLN A 116 | NoneFMN A 500 (-3.6A)FMN A 500 (-3.5A)FMN A 500 (-4.0A)FMN A 500 (-3.0A)FMN A 500 (-4.3A)FMN A 500 (-4.2A)FMN A 500 (-4.3A)FMN A 500 (-4.5A) | 0.64A | 4kukA-5j3wA:16.2 | 4kukA-5j3wA:30.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lmx | DNA-DIRECTED RNAPOLYMERASES I ANDIII SUBUNITRPAC1,DNA-DIRECTEDRNA POLYMERASES IAND III SUBUNITRPAC1 (Saccharomycescerevisiae) |
PF01000(RNA_pol_A_bac)PF01193(RNA_pol_L) | 5 | VAL C 162ASN C 137ASN C 88LEU C 97ILE C 101 | VAL C 162 ( 0.6A)ASN C 137 ( 0.6A)ASN C 88 ( 0.6A)LEU C 97 ( 0.5A)ILE C 101 ( 0.6A) | 1.34A | 4kukA-5lmxC:undetectable | 4kukA-5lmxC:16.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5svw | ADAGIO PROTEIN 1 (Arabidopsisthaliana) |
no annotation | 5 | ARG B 55GLN B 58ASN B 95ASN B 105ILE B 20 | FMN B5201 (-3.8A)FMN B5201 (-3.1A)FMN B5201 (-2.4A)FMN B5201 (-3.8A)FMN B5201 (-2.9A) | 1.42A | 4kukA-5svwB:16.5 | 4kukA-5svwB:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5svw | ADAGIO PROTEIN 1 (Arabidopsisthaliana) |
no annotation | 8 | ASN B 53CYH B 54ARG B 55GLN B 58ASN B 95ASN B 105LEU B 107GLN B 126 | FMN B5201 (-2.9A)FMN B5201 (-3.3A)FMN B5201 (-3.8A)FMN B5201 (-3.1A)FMN B5201 (-2.4A)FMN B5201 (-3.8A)FMN B5201 ( 4.5A)FMN B5201 (-3.8A) | 0.86A | 4kukA-5svwB:16.5 | 4kukA-5svwB:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5svw | ADAGIO PROTEIN 1 (Arabidopsisthaliana) |
no annotation | 5 | ASN B 53CYH B 54ARG B 55LEU B 109ILE B 122 | FMN B5201 (-2.9A)FMN B5201 (-3.3A)FMN B5201 (-3.8A)FMN B5201 (-4.0A)FMN B5201 (-3.1A) | 0.98A | 4kukA-5svwB:16.5 | 4kukA-5svwB:33.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cr0 | (S)-6-HYDROXYNICOTINE OXIDASE (Shinella sp.HZN7) |
no annotation | 5 | ASN A 315ASN A 368LEU A 342ILE A 340GLN A 337 | None | 1.42A | 4kukA-6cr0A:undetectable | 4kukA-6cr0A:24.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fml | INO80 (Chaetomiumthermophilum) |
no annotation | 5 | ASN G 992CYH G1128ARG G1129GLN G1102ILE G1105 | None | 1.39A | 4kukA-6fmlG:undetectable | 4kukA-6fmlG:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 5 | ASN A 47ASN A 71CYH A 72ASN A 104ILE A 88 | FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-3.7A)FMN A 500 (-3.0A)FMN A 500 (-4.1A) | 1.47A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 7 | VAL A 38SER A 40ASN A 47ASN A 71ARG A 73GLN A 76ASN A 104 | FMN A 500 (-4.8A)FMN A 500 (-3.1A)FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-4.5A)FMN A 500 (-4.2A)FMN A 500 (-3.0A) | 0.84A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 11 | VAL A 38SER A 40ASN A 47ASN A 71CYH A 72ARG A 73ASN A 104ASN A 114LEU A 116ILE A 118GLN A 135 | FMN A 500 (-4.8A)FMN A 500 (-3.1A)FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-3.7A)FMN A 500 (-4.5A)FMN A 500 (-3.0A)FMN A 500 (-4.0A)FMN A 500 (-4.1A)NoneFMN A 500 (-3.8A) | 0.66A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbv | PUTATIVE BLUE-LIGHTPHOTORECEPTOR (Dinoroseobactershibae) |
no annotation | 6 | VAL A 38SER A 40ASN A 47ASN A 71CYH A 72ASN A 104 | FMN A 500 (-4.8A)FMN A 500 (-3.1A)FMN A 500 ( 3.7A)FMN A 500 ( 3.2A)FMN A 500 (-3.7A)FMN A 500 (-3.0A) | 1.12A | 4kukA-6gbvA:25.8 | 4kukA-6gbvA:undetectable |